NeoGenomics’ $230 Million Common Stock Offering and $345 Million Convertible Senior Notes Offering

Davis Polk advised the joint book-running managers in the deal. NeoGenomics, Inc. executed its $345 million aggregate principal amount of its 0.250% convertible senior notes due…

This content is for members only.
Login to Read More Join Now
Avatar

Author: Ambrogio Visconti

This content is for members only.
Login to Read More Join Now